` 9996 (Peijia Medical Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

9996
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of 36% compared to the Hang Seng (Hong Kong)'s 37% growth.

Stocks Performance
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Add Stock

Performance Gap
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Difference

Performance By Year
9996 vs Hang Seng (Hong Kong)

Loading
9996
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Peijia Medical Ltd vs Peers

Hang Seng (Hong Kong)
9996
ABT
ISRG
BSX
SYK
Add Stock

Peijia Medical Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
11.04 HKD
Undervaluation 55%
Intrinsic Value
Price
P
Back to Top